SY
Syncona
SYNC.L·LSELondon UKFounded 201240 employees
Small CapbiotechPublicOncologyRare Disease
Platform: LS HealthTech VC
Market Cap
$0.6B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (SYNC.L)
Loading SYNC.L stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SYN-6765 | SYN-6765 | Approved | 3 | PD-L1 | CeliacPSP | ||
| SYN-2281 | SYN-2281 | Phase 1/2 | 1 | CD19 | MCCPNH |
SEC Filings & Financial Documents
SEC filings are not available for LSE-listed companies.
Syncona trades on LSE (GB). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)